Sequase XR
Sequase XR is a generic from Cheplapharm Schweiz GmbH and is listed on the FOPH Specialities List. Basic health insurance reimburses it within the authorised indication. The public price ranges from CHF 49.60 to CHF 273.15 depending on the pack; the co-payment is 10 per cent.
Core data
- Authorisation holder
- Cheplapharm Schweiz GmbH
- ATC code
- N05AH04
- IT group
- 01.05 Neuroleptica
- Active substances
- Quetiapinum
- Preparation type
- Generic
- On the SL since
- 01/06/2015
- Last price change
- 01/06/2017
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Ret Tabl 50 mg | 60 Stk | CHF 30.50 | CHF 49.60 | 01/06/2015 | B | 7680632550017 |
| Ret Tabl 150 mg | 60 Stk | CHF 58.37 | CHF 79.90 | 01/06/2015 | B | 7680632550024 |
| Ret Tabl 150 mg | 100 Stk | CHF 97.28 | CHF 122.20 | 01/06/2015 | B | 7680632550031 |
| Ret Tabl 200 mg | 60 Stk | CHF 72.21 | CHF 94.95 | 01/06/2015 | B | 7680632550048 |
| Ret Tabl 200 mg | 100 Stk | CHF 118.55 | CHF 145.35 | 01/06/2015 | B | 7680632550055 |
| Ret Tabl 300 mg | 60 Stk | CHF 102.04 | CHF 127.40 | 01/06/2015 | B | 7680632550062 |
| Ret Tabl 300 mg | 100 Stk | CHF 167.32 | CHF 198.40 | 01/06/2015 | B | 7680632550079 |
| Ret Tabl 400 mg | 60 Stk | CHF 141.64 | CHF 170.45 | 01/06/2015 | B | 7680632550086 |
| Ret Tabl 400 mg | 100 Stk | CHF 236.06 | CHF 273.15 | 01/06/2015 | B | 7680632550093 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
- Behandlung manischer und depressiver Episoden bei bipolaren Störungen (Akutbehandlung und Rückfallprophylaxe).
- Zusatzbehandlung depressiver Episoden (Episoden einer Major Depression):
Für Patienten, die unzureichend auf die Monotherapie mit mindestens einem Antidepressivum angesprochen haben, im Sinne einer Augmentationsstrategie nach einer gemäss gängigen klinischen Guidelines durchgeführten antidepressiven Therapie. Als Alternative zur Lithiumtherapie bei unzureichendem Ansprechen auf eine Lithiumtherapie, bei bestehender Kontraindikation für eine Lithiumtherapie und bei depressiven Patienten mit psychotischen Symptomen. Vor Beginn der Therapie sollte der behandelnde Arzt das Sicherheitsprofil von Sequase XR abwägen.
More preparations in this group
FAQ
Is Sequase XR covered by Swiss health insurance?
Yes, but only under conditions. Sequase XR is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Sequase XR cost in Switzerland?
The public price is the maximum price set by the FOPH and for Sequase XR ranges from CHF 49.60 to CHF 273.15 per pack. The ex-factory price ranges from CHF 30.50 to CHF 236.06. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages